Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
Status:
Recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The research objectives is to compare vitro 3D drug sensitivity test results of micro tumor
(PTC) with the clinical outcomes of patients, evaluate the consistency between the test
results of the technology platform and the clinical prognosis, and explore the
decision-making value and guiding significance of this technology in assisting the precise
treatment of colorectal cancer. The completion of this study will provide real-world data
support for the clinical application of micro tumor (PTC) in vitro 3D drug sensitivity
detection technology, and provide more valuable reference basis for realizing the
individualization and accuracy of colorectal cancer treatment and improving the clinical
benefit rate.